BioLife Solutions
BLFS
174 hedge funds and large institutions have $874M invested in BioLife Solutions in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 77 increasing their positions, 41 reducing their positions, and 9 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
156% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 9
88% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 41
72% more capital invested
Capital invested by funds: $509M → $874M (+$364M)
9% more funds holding
Funds holding: 160 → 174 (+14)
3.25% more ownership
Funds ownership: 86.89% → 90.14% (+3.2%)
28% less call options, than puts
Call options by funds: $591K | Put options by funds: $817K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$11.2M |
| 2 |
FAM
Fred Alger Management
New York
|
+$8.32M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$8.29M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
+$8.16M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.9M |
| 2 |
Renaissance Technologies
New York
|
-$2.48M |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
-$2.13M |
| 4 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
-$1.79M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.3M |
BLFS Hedge Fund Activity: Q3 2022 in Review
174 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2022, worth a combined $874M — up 72% from $509M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new BLFS positions and 9 closed out — a net gain of 14 holders — while 77 added to existing stakes and 41 trimmed.
The largest buyer was BlackRock, adding an estimated $11.2M. The largest seller was Millennium Management, cutting an estimated $16.9M.
- 174 institutional investors held BioLife Solutions (BLFS) as of Q3 2022, up from 160 in Q2 2022.
- Funds reported $874M of BioLife Solutions stock for Q3 2022, up 72% quarter-over-quarter.
- 23 funds opened new BioLife Solutions positions in Q3 2022 and 9 closed out, a net change of +14 holders.
- The largest BioLife Solutions buyer in Q3 2022 was BlackRock, an estimated $11.2M added.
- The largest BioLife Solutions seller in Q3 2022 was Millennium Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q3 2022.